Clinical Trial: A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013)

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922174) titled 'A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013)' on Nov. 02.

Brief Summary: The purpose of this study is to learn what happens to MK-6916 in a person's body when given to participants with moderate or severe kidney impairment compared to healthy participants.

Study Start Date: Dec. 11

Study Type: INTERVENTIONAL

Condition: Healthy Renal Impairment

Intervention: DRUG: MK-6916

Oral tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Published by HT Digital Content Services with permission from Health Daily Digest....